BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04837651-completion@plaintrial.com
DTSTAMP:20261027T062630Z
DTSTART;VALUE=DATE:20210701
SUMMARY:Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sc
 lerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Nata
 lizumab — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04837651
URL:https://plaintrial.com/trial/NCT04837651
END:VEVENT
END:VCALENDAR
